Endometrioid carcinoma of the ovary.A clinicopathologic study of 75 cases

B Czernobilsky, Bernard Czernobilsky, Barney B. Silverman, B B Silverman, J J Mikuta, John J. Mikuta
Cancer · 1970 · vol. 26(5) , pp. 1141–1152 · doi:10.1002/1097-0142(197011)26:5<1141::aid-cncr2820260526>3.0.co;2-r · PMID:5476794 · W2049883475
article OA: bronze CC0 ⤵ 26 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This clinicopathologic study of 75 ovarian endometrioid carcinomas found survival correlated best with clinical staging, with 5-year survival at 92.5% in Stage I and decreasing dramatically in later stages.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A clinicopathologic study of 75 endometrioid carcinomas of the ovary was carried out. Thirty-six of the patients were in clinical Stages I and II and 39 in Stages III and IV. There were 49 histologically “pure” endometrioid carcinomas. the remaining 26 showed histologic admixtures of other neoplasms of Müllerian derivation. Thirty-six of the 75 cases were adenoacanthomas. By histologic grading, 45 were classified as Grades 1 and 2, 30 as Grades 3 and 4. Thirteen of the ovaries with carcinoma also harbored endometriosis. in 11 patients, there was a concomitant endometrial carcinoma. the 5- and 10-year survival figures for the entire series were 40.5% and 32.7%. Survival did not differ significantly between various subgroups or with different modalities of treatment and correlated best with clinical staging. Five-year survival was 92.5% in Stage I and 27.8%, 3.7%, and 0% in Stages II, III, and IV.

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Adenocarcinoma Endometriosis Ovarian Neoplasms Adenocarcinoma Adenocarcinoma Adult Aged Endometriosis Endometriosis Female Humans Middle Aged Ovarian Neoplasms Ovarian Neoplasms Pennsylvania Prognosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (23)

Cited by (26)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-14T05:59:19.139991+00:00
License: CC0 · commercial use OK